{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:11:03Z","timestamp":1772165463738,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Dutch Research Council domain Applied and Engineered Sciences","award":["15494"],"award-info":[{"award-number":["15494"]}]},{"name":"The Max Planck Society"},{"name":"Max Planck Institute for Developmental Biology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding the synergetic and antagonistic effects of combinations of drugs and toxins is vital for many applications, including treatment of multifactorial diseases and ecotoxicological monitoring. Synergy is usually assessed by comparing the response of drug combinations to a predicted non-interactive response from reference (null) models. Possible choices of null models are Loewe additivity, Bliss independence and the recently rediscovered Hand model. A different approach is taken by the MuSyC model, which directly fits a generalization of the Hill model to the data. All of these models, however, fit the dose\u2013response relationship with a parametric model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We propose the Hand-GP model, a non-parametric model based on the combination of the Hand model with Gaussian processes. We introduce a new logarithmic squared exponential kernel for the Gaussian process which captures the logarithmic dependence of response on dose. From the monotherapeutic response and the Hand principle, we construct a null reference response and synergy is assessed from the difference between this null reference and the Gaussian process fitted response. Statistical significance of the difference is assessed from the confidence intervals of the Gaussian process fits. We evaluate performance of our model on a simulated data set from Greco, two simulated data sets of our own design and two benchmark data sets from Chou and Talalay. We compare the Hand-GP model to standard synergy models and show that our model performs better on these data sets. We also compare our model to the MuSyC model as an example of a recent method on these five data sets and on two-drug combination screens: Mott et al. anti-malarial screen and O\u2019Neil et al. anti-cancer screen. We identify cases in which the HandGP model is preferred and cases in which the MuSyC model is preferred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Hand-GP model is a flexible model to capture synergy. Its non-parametric and probabilistic nature allows it to model a wide variety of response patterns.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-021-04508-7","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T04:03:03Z","timestamp":1641441783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Non-parametric synergy modeling of chemical compounds with Gaussian processes"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuliya","family":"Shapovalova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Heskes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-701X","authenticated-orcid":false,"given":"Tjeerd","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"1\u20132","key":"4508_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","volume":"12","author":"GR Zimmermann","year":"2007","unstructured":"Zimmermann GR, Lehar J, Keith CT. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today. 2007;12(1\u20132):34\u201342.","journal-title":"Drug Discov Today"},{"issue":"16","key":"4508_CR2","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/jnci\/djr246","volume":"103","author":"RW Humphrey","year":"2011","unstructured":"Humphrey RW, Brockway-Lunardi LM, Bonk DT, Dohoney KM, Doroshow JH, Meech SJ, Ratain MJ, Topalian SL, Pardoll DM. Opportunities and challenges in the development of experimental drug combinations for cancer. J Natl Cancer Inst. 2011;103(16):1222\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4508_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1067\/mai.2001.112939","volume":"107","author":"HS Nelson","year":"2001","unstructured":"Nelson HS. Advair: combination treatment with fluticasone propionate\/salmeterol in the treatment of asthma. J Allergy Clin Immunol. 2001;107(2):397\u2013416.","journal-title":"J Allergy Clin Immunol"},{"key":"4508_CR4","first-page":"285","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953;3:285\u201390.","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"4508_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"C Bliss","year":"1939","unstructured":"Bliss C. The toxicity of poisons applied jointly. Ann Appl Biol. 1939;26(3):585\u2013615.","journal-title":"Ann Appl Biol"},{"issue":"2","key":"4508_CR6","first-page":"93","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum MC. What is synergy? Pharmacol Rev. 1989;41(2):93\u2013141.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"4508_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1124\/jpet.104.067264","volume":"310","author":"Y Grabovsky","year":"2004","unstructured":"Grabovsky Y, Tallarida RJ. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther. 2004;310(3):981\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4508_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-38907-x","volume":"9","author":"M Sinzger","year":"2019","unstructured":"Sinzger M, Vanhoefer J, Loos C, Hasenauer J. Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible. Sci Rep. 2019;9(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"10","key":"4508_CR9","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1897\/04-431R.1","volume":"24","author":"MJ Jonker","year":"2005","unstructured":"Jonker MJ, Svendsen C, Bedaux JJ, Bongers M, Kammenga JE. Significance testing of synergistic\/antagonistic, dose level-dependent, or dose ratio-dependent effects in mixture dose\u2013response analysis. Environ Toxicol Chem Int J. 2005;24(10):2701\u201313.","journal-title":"Environ Toxicol Chem Int J"},{"issue":"1","key":"4508_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/s41467-017-01929-y","volume":"8","author":"SG Wicha","year":"2017","unstructured":"Wicha SG, Chen C, Clewe O, Simonsson US. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions. Nat Commun. 2017;8(1):2129.","journal-title":"Nat Commun"},{"key":"4508_CR11","first-page":"4","volume":"40","author":"AV Hill","year":"1910","unstructured":"Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol. 1910;40:4\u20137.","journal-title":"J Physiol"},{"issue":"8","key":"4508_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/etc.5620150824","volume":"15","author":"CN Haas","year":"1996","unstructured":"Haas CN, Cidambi K, Kersten S, Wright K. Quantitative description of mixture toxicity: effect of level of response on interactions. Environ Toxicol Chem Int J. 1996;15(8):1429\u201337.","journal-title":"Environ Toxicol Chem Int J"},{"issue":"24","key":"4508_CR13","doi-asserted-by":"publisher","first-page":"14461","DOI":"10.1021\/acs.est.8b04752","volume":"52","author":"F Larras","year":"2018","unstructured":"Larras F, Billoir E, Baillard V, Siberchicot A, Scholz S, Wubet T, Tarkka M, Schmitt-Jansen M, Delignette-Muller M-L. DRomics: a Turnkey Tool to support the use of the dose\u2013response framework for omics data in ecological risk assessment. Environ Sci Technol. 2018;52(24):14461\u20138.","journal-title":"Environ Sci Technol"},{"key":"4508_CR14","doi-asserted-by":"publisher","DOI":"10.1201\/9780367815493","volume-title":"Surrogates: Gaussian process modeling, design, and optimization for the applied sciences","author":"RB Gramacy","year":"2020","unstructured":"Gramacy RB. Surrogates: Gaussian process modeling, design, and optimization for the applied sciences. Boca Raton: CRC Press; 2020."},{"key":"4508_CR15","doi-asserted-by":"crossref","unstructured":"R\u00f8nneberg L, Cremaschi A, Hanes R, Enserink J, Zucknick M. bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in-vitro drug combination experiments (2021). bioRxiv","DOI":"10.1101\/2021.04.07.438787"},{"issue":"2","key":"4508_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cels.2019.01.003","volume":"8","author":"CT Meyer","year":"2019","unstructured":"Meyer CT, Wooten DJ, Paudel BB, Bauer J, Hardeman KN, Westover D, Lovly CM, Harris LA, Tyson DR, Quaranta V. Quantifying drug combination synergy along potency and efficacy axes. Cell Syst. 2019;8(2):97\u2013108.","journal-title":"Cell Syst"},{"issue":"1","key":"4508_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24789-z","volume":"12","author":"DJ Wooten","year":"2021","unstructured":"Wooten DJ, Meyer CT, Lubbock AL, Quaranta V, Lopez CF. MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery. Nat Commun. 2021;12(1):1\u201316.","journal-title":"Nat Commun"},{"key":"4508_CR18","series-title":"Lecture Notes in Computer Science","volume-title":"Advanced Lectures on Machine Learning","author":"CE Rasmussen","year":"2003","unstructured":"Rasmussen CE. Gaussian processes in machine learning. In: Bousquet O, von Luxburg U, R\u00e4tsch G, editors. Advanced Lectures on Machine Learning. ML 2003, vol. 3176., Lecture Notes in Computer Science. Berlin, Heidelberg: Springer; 2003."},{"issue":"2","key":"4508_CR19","first-page":"331","volume":"47","author":"WR Greco","year":"1995","unstructured":"Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 1995;47(2):331\u201385.","journal-title":"Pharmacol Rev"},{"key":"4508_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou T-C, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27\u201355.","journal-title":"Adv Enzyme Regul"},{"issue":"10","key":"4508_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btaa826","volume":"37","author":"DJ Wooten","year":"2020","unstructured":"Wooten DJ, Albert R. synergy-a python library for calculating, analyzing, and visualizing drug combination synergy. Bioinformatics. 2020;37(10):1473\u20134.","journal-title":"Bioinformatics"},{"key":"4508_CR22","volume-title":"Bootstrap methods: a guide for practitioners and researchers","author":"MR Chernick","year":"2011","unstructured":"Chernick MR. Bootstrap methods: a guide for practitioners and researchers, vol. 619. Hoboken: Wiley; 2011."},{"key":"4508_CR23","volume-title":"Computational geometry algorithms and applications","author":"DB Mark","year":"2008","unstructured":"Mark DB, Otfried C, Marc VK, Mark O. Computational geometry algorithms and applications. Berlin: Springer; 2008."},{"key":"4508_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0003-9861(64)90184-5","volume":"106","author":"T Yonetani","year":"1964","unstructured":"Yonetani T, Theorell H. Studies on liver alcohol dehydrogenase complexes. III: multiple inhibition kinetics in the presence of two competitive inhibitors. Arch Biochem Biophys. 1964;106:243\u201351.","journal-title":"Arch Biochem Biophys"},{"key":"4508_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","volume":"115","author":"T-C Chou","year":"1981","unstructured":"Chou T-C, Talalay P. Generalized equations for the analysis of inhibitions of Michaelis\u2013Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem. 1981;115:207\u201316.","journal-title":"Eur J Biochem"},{"key":"4508_CR26","doi-asserted-by":"crossref","unstructured":"Wooten DJ, Meyer CT, Quaranta V, Lopez C. A consensus framework unifies multi-drug synergy metrics. 2019. p. 683433. BioRxiv","DOI":"10.1101\/683433"},{"issue":"1","key":"4508_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep13891","volume":"5","author":"BT Mott","year":"2015","unstructured":"Mott BT, Eastman RT, Guha R, Sherlach KS, Siriwardana A, Shinn P, McKnight C, Michael S, Lacerda-Queiroz N, Patel PR, et al. High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations. Sci Rep. 2015;5(1):1\u201314.","journal-title":"Sci Rep"},{"key":"4508_CR28","doi-asserted-by":"crossref","unstructured":"O\u2019Neil J, Benita Y, Feldman I, Chenard M, Roberts B, Liu Y, Li J, Kral A, Lejnine S, Loboda A, et al. An unbiased oncology compound screen to identify novel combination strategies. Mol Cancer Ther. 2016;15(6):1155\u201362.","DOI":"10.1158\/1535-7163.MCT-15-0843"},{"key":"4508_CR29","doi-asserted-by":"publisher","first-page":"60352","DOI":"10.7554\/eLife.60352","volume":"9","author":"D Wang","year":"2020","unstructured":"Wang D, Hensman J, Kutkaite G, Toh TS, Galhoz A, Dry JR, Saez-Rodriguez J, Garnett MJ, Menden MP, Dondelinger F, et al. A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates. Elife. 2020;9:60352.","journal-title":"Elife"},{"issue":"6","key":"4508_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.3853","volume":"13","author":"M Hafner","year":"2016","unstructured":"Hafner M, Niepel M, Chung M, Sorger PK. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat Methods. 2016;13(6):521\u20137.","journal-title":"Nat Methods"},{"key":"4508_CR31","doi-asserted-by":"publisher","unstructured":"Alvarez MA, Rosasco L, Lawrence ND. Kernels for vector-valued functions: a review. Found Trends$$^{\\textregistered }$$ Mach Learn. 2012;4(3):195\u2013266. https:\/\/doi.org\/10.1561\/2200000036.","DOI":"10.1561\/2200000036"},{"key":"4508_CR32","first-page":"217","volume":"17","author":"P Boyle","year":"2005","unstructured":"Boyle P, Frean M. Dependent Gaussian processes. Adv Neural Inf Process Syst. 2005;17:217\u201324.","journal-title":"Adv Neural Inf Process Syst"},{"issue":"3","key":"4508_CR33","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1137\/17M1153157","volume":"6","author":"AF L\u00f3pez-Lopera","year":"2018","unstructured":"L\u00f3pez-Lopera AF, Bachoc F, Durrande N, Roustant O. Finite-dimensional Gaussian approximation with linear inequality constraints. SIAM\/ASA J Uncertain Quantif. 2018;6(3):1224\u201355.","journal-title":"SIAM\/ASA J Uncertain Quantif"},{"key":"4508_CR34","unstructured":"Maatouk H. Finite-dimensional approximation of Gaussian processes with inequality constraints (2017). arXiv:1706.02178"},{"key":"4508_CR35","first-page":"1215","volume":"30","author":"C Jidling","year":"2017","unstructured":"Jidling C, Wahlstr\u00f6m N, Wills A, Sch\u00f6n TB. Linearly constrained Gaussian processes. Adv Neural Inf Process Syst. 2017;30:1215\u201324.","journal-title":"Adv Neural Inf Process Syst."},{"issue":"Dec","key":"4508_CR36","first-page":"2651","volume":"7","author":"CA Micchelli","year":"2006","unstructured":"Micchelli CA, Xu Y, Zhang H. Universal kernels. J Mach Learn Res. 2006;7(Dec):2651\u201367.","journal-title":"J Mach Learn Res"},{"key":"4508_CR37","unstructured":"Duvenaud D. Automatic model construction with Gaussian processes. PhD thesis, University of Cambridge; 2014"},{"issue":"2","key":"4508_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0370-2693(87)91197-X","volume":"195","author":"S Duane","year":"1987","unstructured":"Duane S, Kennedy AD, Pendleton BJ, Roweth D. Hybrid Monte Carlo. Phys Lett B. 1987;195(2):216\u201322.","journal-title":"Phys Lett B"},{"key":"4508_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fphar.2018.00031","volume":"9","author":"S Lederer","year":"2018","unstructured":"Lederer S, Dijkstra TM, Heskes T. Additive dose response models: explicit formulation and the Loewe additivity consistency condition. Front Pharmacol. 2018;9:31.","journal-title":"Front Pharmacol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-021-04508-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T20:03:31Z","timestamp":1641499411000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-04508-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4508"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-04508-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.02.438180","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Does not apply\u2014we used only published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}